Combining Curcumin With FOLFOX Chemotherapy in Patients With Inoperable Colorectal Cancer
A Phase I/IIa Study Combining Curcumin (Curcumin C3-Complex, Sabinsa) With Standard Care FOLFOX Chemotherapy in Patients With Inoperable Colorectal Cancer.
Sponsor: University of Leicester
Listed as NCT01490996, this PHASE1/PHASE2 trial focuses on Colonic Cancer and Metastasis and remains completed. Sponsored by University of Leicester, it has been updated 7 times since 2012, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
-
Feb 2020 — Jan 2021 [monthly]
Completed PHASE1_PHASE2
Status: Unknown Status → Completed
-
Jun 2019 — Feb 2020 [monthly]
Unknown Status PHASE1_PHASE2
Status: Active Not Recruiting → Unknown Status
▶ Show 2 earlier versions
-
Jun 2018 — Jun 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE1_PHASE2
First recorded
Feb 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Leicester
For direct contact, visit the study record on ClinicalTrials.gov .